Secondary metabolites: The focus of biodiscovery and perhaps the key to unlocking new depths in taxonomy

Abstract

Drug discovery is driven, either directly or indirectly, by biodiversity. Over half of the new chemical entities approved by regulatory authorities over the past decade are from natural sources. Australia?s natural resources contain unique, diverse and geographically distinct pools of biodiversity that have been only superficially utilised.